Results 81 to 90 of about 119,061 (97)

Opinión y Noticias

open access: yesRevista Iberoamericana de Automática e Informática Industrial RIAI, 2011
doaj   +1 more source

Presentación

open access: yesRevista Iberoamericana de Automática e Informática Industrial RIAI
José Manuel Andújar
doaj  

Nota de Redacción

open access: yesRevista Iberoamericana de Automática e Informática Industrial RIAI
Pedro Albertos   +3 more
doaj  
Some of the next articles are maybe not open access.

Related searches:

A review of recent advancements in Actinium‐225 labeled compounds and biomolecules for therapeutic purposes

Chemical Biology and Drug Design, 2023
In nuclear medicine, cancers that cannot be cured or can only be treated partially by traditional techniques like surgery or chemotherapy are killed by ionizing radiation as a form of therapeutic treatment.
Maria Hassan   +4 more
semanticscholar   +1 more source

Theranostic Nuclear Medicine with Gallium-68, Lutetium-177, Copper-64/67, Actinium-225, and Lead-213/203 Radionuclides.

Chemical Reviews, 2023
Molecular changes in malignant tissue can lead to an increase in the expression levels of various proteins or receptors that can be used to target the disease.
Katherine A Morgan   +3 more
semanticscholar   +1 more source

225-Gb/s PAM4 Operation Using Lumped-Electrode-Type EA-DFB Laser for 5- and 10-km Transmission with Low TDECQ

Optical Fiber Communications Conference and Exhibition, 2023
Both 5-km and 10-km transmission was demonstrated under 225-Gb/s PAM4 operation using EA-DFB lasers. We confirmed low TDECQ values of 2.0~3.2 dB for 5 km in the CWDM range and 10 km at 1293.5 nm.
Kazuki Nishimura   +9 more
semanticscholar   +1 more source

Toward Personalized Medicine: One Chelator for Imaging and Therapy with Lutetium-177 and Actinium-225.

Journal of the American Chemical Society, 2022
We report a nonadentate bispidine (3,7-diazabicyclo[3.3.1]nonane) that unveils the potential to bind theranostically relevant radionuclides, including indium-111, lutetium-177, and actinium-225 under mild labeling conditions.
P. Cieslik   +11 more
semanticscholar   +1 more source

Challenges and opportunities in developing Actinium-225 radiopharmaceuticals

Nuclear medicine communications, 2022
Actinium-225 (225Ac) has emerged as a promising therapeutic radioisotope for targeted alpha therapy. It emits net four alpha particles during its decay to stable daughter bismuth-209, rightly called an in-vivo nano-generator.
Deeksha Dhiman, Rakhee Vatsa, A. Sood
semanticscholar   +1 more source

Synthesis and Evaluation of a New Macrocyclic Actinium-225 Chelator, Quality Control and in Vivo Evaluation of 225Ac-crown-αMSH Peptide.

Chemistry, 2020
Targeted alpha-therapy (TAT) has great potential for treating a broad range of late stage cancers by delivering a focused and lethal radiation dose to tumors.
Hua Yang   +11 more
semanticscholar   +1 more source

A novel endogenous antimicrobial peptide CAMP211-225 derived from casein in human milk.

Food & Function, 2020
A large number of bioactive peptides derived from breast milk have been identified to be multifunctional having anti-inflammatory, immunoregulatory and antimicrobial activities. Here, we report that an endogenous peptide located at β-casein 211-225 amino
Xing Wang   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy